These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38621613)

  • 21. Combinational Inhibition of P-Glycoprotein-Mediated Etoposide Transport by Zosuquidar and Polysorbate 20.
    Nielsen RB; Holm R; Pijpers I; Snoeys J; Nielsen UG; Nielsen CU
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polysorbate 20 alters the oral bioavailability of etoposide in wild type and mdr1a deficient Sprague-Dawley rats.
    Al-Ali AAA; Quach JRC; Bundgaard C; Steffansen B; Holm R; Nielsen CU
    Int J Pharm; 2018 May; 543(1-2):352-360. PubMed ID: 29635055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.
    Bentz J; O'Connor MP; Bednarczyk D; Coleman J; Lee C; Palm J; Pak YA; Perloff ES; Reyner E; Balimane P; Brännström M; Chu X; Funk C; Guo A; Hanna I; Herédi-Szabó K; Hillgren K; Li L; Hollnack-Pusch E; Jamei M; Lin X; Mason AK; Neuhoff S; Patel A; Podila L; Plise E; Rajaraman G; Salphati L; Sands E; Taub ME; Taur JS; Weitz D; Wortelboer HM; Xia CQ; Xiao G; Yabut J; Yamagata T; Zhang L; Ellens H
    Drug Metab Dispos; 2013 Jul; 41(7):1347-66. PubMed ID: 23620485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1.
    Shang H; Sun Y; Wang Z; Zhou Y; Yang H; Ci X; Cui T; Xia Y; Gu Y; Liao M; Li Q; Si D; Liu C
    J Ethnopharmacol; 2022 May; 289():115006. PubMed ID: 35051604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketoconazole and the modulation of multidrug resistance-mediated transport in Caco-2 and MDCKII-MDR1 drug transport models.
    Fan Y; Rodriguez-Proteau R
    Xenobiotica; 2008 Feb; 38(2):107-29. PubMed ID: 18197554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrapolation of Elementary Rate Constants of P-glycoprotein-Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells.
    Meng Z; Ellens H; Bentz J
    Drug Metab Dispos; 2017 Feb; 45(2):190-197. PubMed ID: 27856526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.
    Reznicek J; Ceckova M; Ptackova Z; Martinec O; Tupova L; Cerveny L; Staud F
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro investigation regarding the effects of Gelucire
    Dubray O; Jannin V; Demarne F; Pellequer Y; Lamprecht A; Béduneau A
    Int J Pharm; 2016 Dec; 515(1-2):293-299. PubMed ID: 27720954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
    Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R
    Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dabigatran Etexilate and Digoxin: Comparison as Clinical Probe Substrates for Evaluation of P-gp Inhibition.
    Chu X; Galetin A; Zamek-Gliszczynski MJ; Zhang L; Tweedie DJ;
    Clin Pharmacol Ther; 2018 Nov; 104(5):788-792. PubMed ID: 30238965
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells.
    Li YX; Ye LH; Jiang XH; Peng C
    Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):41-7. PubMed ID: 21336515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
    Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
    J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
    Zhang Y; Wang C; Liu Z; Meng Q; Huo X; Liu Q; Sun P; Yang X; Sun H; Ma X; Liu K
    Pharmacol Rep; 2018 Apr; 70(2):243-250. PubMed ID: 29475007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
    Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
    Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
    Dimitrijevic D; Shaw AJ; Florence AT
    J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.
    Yue GG; Cheng SW; Yu H; Xu ZS; Lee JK; Hon PM; Lee MY; Kennelly EJ; Deng G; Yeung SK; Cassileth BR; Fung KP; Leung PC; Lau CB
    J Med Food; 2012 Mar; 15(3):242-52. PubMed ID: 22181075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.